Resultados de procura - Alejandra Gurtman
- Mostrando 1 - 20 Resultados de 41
- Go to Next Page
-
1
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial por Takeo Otsuki, Shinobu Akada, Ai Anami, Kenzo Kosaka, Iona Munjal, James Baber, Yasuko Shoji, Masakazu Aizawa, Kena A. Swanson, Alejandra Gurtman
Publicado 2024Artigo -
2
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial por Ron Dagan, Scott D. Patterson, Christine Juergens, David Greenberg, Noga Givon‐Lavi, Nurith Porat, Alejandra Gurtman, William C. Gruber, Daniel A. Scott
Publicado 2013Artigo -
3
Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible<i>Streptococcus pne... por Ron Dagan, Christine Juergens, James Trammel, Scott D. Patterson, David Greenberg, Noga Givon‐Lavi, Nurith Porat, Alejandra Gurtman, William C. Gruber, Daniel A. Scott
Publicado 2014Artigo -
4
-
5
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies por Elizabeth Begier, David Seiden, Michael A. Patton, Edward T. Zito, Joseph M. Severs, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, Alejandra Gurtman
Publicado 2017Artigo -
6
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine por Lisa A. Jackson, Alejandra Gurtman, Kathryn Rice, Karlis Pauksens, Richard N. Greenberg, Thomas R. Jones, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma
Publicado 2013Artigo -
7
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults por Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Kathrin U. Jansen, Deepthi Jayawardene, Carmel Devlin, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma
Publicado 2013Artigo -
8
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent... por Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Robert W. Frenck, John Treanor, Kathrin U. Jansen, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma
Publicado 2013Artigo -
9
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination por As’ad E. Bhorat, Shabir A. Madhi, France Laudat, Vani Sundaraiyer, Alejandra Gurtman, Kathrin U. Jansen, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma
Publicado 2015Artigo -
10
Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults por Robert W. Frenck, Alejandra Gurtman, John Rubino, William Smith, Martin van Cleeff, Deepthi Jayawardene, Peter C. Giardina, Emilio A. Emini, William C. Gruber, Daniel A. Scott, Beate Schmöele-Thoma
Publicado 2012Artigo -
11
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine por James T. Peterson, Agnieszka Zareba, David Fitzpatrick, Brandon Essink, Daniel A. Scott, Kena A. Swanson, Dhawal Chelani, David Radley, David Cooper, Kathrin U. Jansen, Philip R. Dormitzer, William C. Gruber, Alejandra Gurtman
Publicado 2021Artigo -
12
P-605. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High and Durable Neutralizing Titers Across an Entire RSV Season among Older Adults por Jose F Cardona, Tarek Mikati, Yasushi Fukushima, Qin Jiang, Daniel Eiras, John Woodside, Michael Quinn Patton, Kumar Ilangovan, Elena Kalinina, David Cooper, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Iona Munjal
Publicado 2025Artigo -
13
A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults por James Baber, Mark Arya, Yuben Moodley, Anna Jaques, Qin Jiang, Kena A. Swanson, David Cooper, Mohan S. Maddur, Jakob Loschko, Alejandra Gurtman, Kathrin U. Jansen, William C. Gruber, Philip R. Dormitzer, Beate Schmöele-Thoma
Publicado 2022Artigo -
14
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine por Marshall J. Glesby, Wendy Watson, Cynthia Brinson, Richard N. Greenberg, Jacob Lalezari, Daniel J. Skiest, Vani Sundaraiyer, Robert J. Natuk, Alejandra Gurtman, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma
Publicado 2014Artigo -
15
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine por Edward E. Walsh, Ann R. Falsey, Daniel A. Scott, Alejandra Gurtman, Agnieszka Zareba, Kathrin U. Jansen, William C. Gruber, Philip R. Dormitzer, Kena A. Swanson, David Radley, Emily Gomme, David Cooper, Beate Schmöele-Thoma
Publicado 2021Artigo -
16
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vac... por Ann R. Falsey, Edward E. Walsh, Daniel A. Scott, Alejandra Gurtman, Agnieszka Zareba, Kathrin U. Jansen, William C. Gruber, Philip R. Dormitzer, Kena A. Swanson, Qin Jiang, Emily Gomme, David Cooper, Beate Schmöele-Thoma
Publicado 2021Artigo -
17
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine w... por Joel M. Neutel, Rahsan Erdem, Qin Jiang, Kevin Cannon, Helen Stacey, Ryan Newton, Emily Gomme, Wen Li, Federico Mensa, Özlem Türeci, Uğur Şahin, Kena A. Swanson, Iona Munjal, David Cooper, Kenneth Koury, Annaliesa S. Anderson, Alejandra Gurtman, Nicholas Kitchin
Publicado 2025Artigo -
18
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study por Beate Schmöele-Thoma, Agnieszka Zareba, Qin Jiang, Mohan S. Maddur, Rana Danaf, Alex Mann, Kingsley Eze, Juin Fok‐Seang, Golam Kabir, Andrew Catchpole, Daniel A. Scott, Alejandra Gurtman, Kathrin U. Jansen, William C. Gruber, Philip R. Dormitzer, Kena A. Swanson
Publicado 2022Artigo -
19
Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy por Eric A. F. Simões, Kimberly J. Center, Alan Tita, Kena A. Swanson, David Radley, John Houghton, Stephanie McGrory, Emily Gomme, Marquita Anderson, John P. Roberts, Daniel A. Scott, Kathrin U. Jansen, William C. Gruber, Philip R. Dormitzer, Alejandra Gurtman
Publicado 2022Artigo -
20
Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era por Sheldon L. Kaplan, Kimberly J. Center, William J. Barson, Philana Ling-Lin, José R. Romero, John S. Bradley, Tina Q. Tan, Jill A. Hoffman, Timothy R. Peters, Alejandra Gurtman, Daniel A. Scott, James Trammel, William C. Gruber, Kristina G. Hultén, Edward O. Mason
Publicado 2015Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Immunology
Internal medicine
Virology
Immunogenicity
Vaccination
Disease
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Pathology
Adverse effect
Alternative medicine
Antibody
Biology
Placebo
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Microbiology
Randomized controlled trial
Titer
Virus
Antibiotics
Clinical trial
Immune system
Pneumococcal conjugate vaccine
Streptococcus pneumoniae
2019-20 coronavirus outbreak
Outbreak
Pediatrics
Pneumococcal infections
Reactogenicity